Prognostic value of cytokines and neurohormones in severe heart failure;Valor pronóstico de los niveles de citocinas y neurohormonas en la insuficiencia cardíaca severa

Revista Espanola de Cardiologia

Volumn 55, Issue 5, 2002, Pages 481-486

  Vidal, Bèrbara ^a   Roig, Eulèlia ^a   Pérez Villa, Félix ^a   Orús, Josefina ^a   Pérez, Joaquín ^a   Jiménez, Vladimiro ^a   Leivas, Alberto ^a   Cuppoletti, Alfredo ^a   Roqué, Merce ^a   Sanz, Ginés ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Angiotensin II; Cytokines; Heart transplantation; Severe heart failure

Indexed keywords

ALDOSTERONE; AMIODARONE; ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; CYTOKINE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; ENDOTHELIN; FUROSEMIDE; INTERLEUKIN 8; NEUROHORMONE; NORADRENALIN; TUMOR NECROSIS FACTOR ALPHA; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIASTOLE; DISEASE CLASSIFICATION; DISEASE SEVERITY; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART TRANSPLANTATION; HEMODYNAMICS; HORMONE BLOOD LEVEL; HUMAN; LUNG CAPILLARY PRESSURE; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; MEDICAL DECISION MAKING; MORTALITY; PLASMA RENIN ACTIVITY; PROGNOSIS; PROTEIN BLOOD LEVEL; REGRESSION ANALYSIS; SCREENING TEST; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; SYSTOLE; BLOOD; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; FEMALE; HEART FUNCTION TEST; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTION AND FORECASTING;

AGED; BIOLOGICAL MARKERS; CYTOKINES; FEMALE; HEART FAILURE, CONGESTIVE; HEART FUNCTION TESTS; HEART TRANSPLANTATION; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; NEUROTRANSMITTER AGENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 0036017319     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-8932(02)76639-6     Document Type: Article

References (29)

1. Survival after the onset of congestive heart failure in Framingham heart study subjects
2. Trends in hospitalization and mortality for heart failure in Spain, 1980-1993
3. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure
4. Transplant candidates with severe left ventricular dysfunction managed with medical treatment: Characteristics and survival
5. Clinical and hemodynamic predictors of survival in patients aged < 65 years with severe congestive heart failure secondary to ischemic or nonischemic dilated cardiomyopathy
6. Assessment of the appropriateness of the decision of heart transplantation in idiopathic-dilated cardiomyopathy
7. Comparison of mortality rates and progression of left ventricular dysfunction in patients with idiopathic dilated cardiomyopathy and dilated versus nondilated right ventricular cavities
8. Hipertensión arterial pulmonar y transplante cardíaco: Evolución hemodinámica y supervivencia
9. Variables predictoras de mortalidad precoz tras el transplante cardíaco ortotópico en adultos
10. Predicting survival for an individual with congestive heart failure using the plasma norepinephrine concentration
11. Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure
12. Prognostic value of plasma endothelin-1 in patients with chronic heart disease
13. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure
14. Molecular forms and biological activity of atrial natriuretic factor in patients with cirrhosis and ascites
15. Prognostic value of serum cytokines in patients with congestive heart failure
16. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the SOLVD study
17. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure
18. Plasma cytokine parameters and mortality with chronic heart failure
19. Registro Español de Trasplante Cardíaco. IX Informe Oficial (1984-1999)
20. Selection and treatment of candidates for heart transplantation. A statement for health professionals from the committee on heart failure and cardiac transplantation of the council on clinical cardiology
21. Plasma norepinephrine, plasma renin activity and congestive heart failure. Relations to survival and the effects of therapy in V-Heft II
22. Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation
23. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality
24. Clinical implications of increased plasma angiotensin II despite ACE inhibitors therapy in patients with congestive heart failure
25. Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1
26. Outcome of patients with congestive heart failure treated with standard versus high doses of enalapril: A multicentric study
27. Comparison of candesartan, enalapril and their combination in congestive heart failure. Randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study
28. Pronostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure
29. Increased ang-II-dependent, NADPH-oxidase activity in the aorta of young cardiomyopathic hamsters without evidence of heart failure